Tuesday - June 9, 2026

Exon Skipping of Fc-Epsilon-Ri-Beta and MS4A6A in Combination for the Treatment of Allergic Diseases

2026-05-26

ALEXANDRIA, Virginia, May 26 -- NORTH CAROLINA STATE UNIVERSITY, Raleigh, North Carolina has been assigned a patent (No. US 12637677 B2, initially filed Nov. 9, 2020) developed by Glenn P. Cruse, Apex, North Carolina, for "Exon skipping of Fc-epsilon-RI-beta and MS4A6A in combination for the treatment of allergic diseases." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Exon Skipping of Fc-Epsilon-Ri-Beta and MS4A6A in Combination for the Treatment of Allergic Diseases

Information Request Form

Copyright Targeted News Service 2026